Cost-Effectiveness Analysis of Computerized Tomography in the Routine Follow-Up of Patients After Primary Treatment for Hodgkin's Disease

Cost-effectiveness of Routine Computerized Tomography in Follow-up of Patients with Complete Response After Primary Treatment for Hodgkin’s Disease

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2005.07.194 ◽

2005 ◽

Vol 63 ◽

pp. S114-S115

Author(s):

B.A. Guadagnolo ◽

R.S. Punglia ◽

K.M. Kuntz ◽

P.M. Mauch ◽

A.K. Ng

Keyword(s):

Cost Effectiveness ◽

Computerized Tomography ◽

Hodgkin's Disease ◽

Hodgkin’S Disease ◽

Complete Response ◽

Primary Treatment

CRT-500.12 Cost-Effectiveness Analysis of Therapeutic Hypothermia in Critical Patients After Cardiac Arrest: Estimate of Lifetime Horizon Follow-Up

JACC Cardiovascular Interventions ◽

10.1016/j.jcin.2020.01.143 ◽

2020 ◽

Vol 13 (4) ◽

pp. S44-S45

Author(s):

Luis Augusto Dallan ◽

Natali Giannetti ◽

Thatiane Facholi Polastri ◽

Antonio Baruzzi ◽

Gisele Sampaio ◽

...

Keyword(s):

Cardiac Arrest ◽

Cost Effectiveness ◽

Therapeutic Hypothermia ◽

Lifetime Horizon ◽

Effectiveness Analysis ◽

Critical Patients

Cost Effectiveness Analysis of Heparin- Versus Standard Polytetrafluoroethylene Graft alongside a Randomised Controlled Trial with Five Years Follow-Up

European Journal of Vascular and Endovascular Surgery ◽

10.1016/j.ejvs.2016.07.056 ◽

2016 ◽

Vol 52 (3) ◽

pp. 407

Author(s):

M.K. Villemoes ◽

J.S. Lindholt ◽

K.C. Houlind ◽

B. Gottschalksen ◽

C.N. Pedersen ◽

...

Keyword(s):

Cost Effectiveness ◽

Randomised Controlled Trial ◽

Controlled Trial ◽

Effectiveness Analysis ◽

Randomised Controlled

Cost-effectiveness of computerized tomography screening for lung cancer in Hodgkin’s disease survivors

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(03)01023-x ◽

2003 ◽

Vol 57 (2) ◽

pp. S213 ◽

Cited By ~ 1

Author(s):

P Das ◽

A.K Ng ◽

C.C Earle ◽

P.M Mauch ◽

K.M Kuntz

Keyword(s):

Lung Cancer ◽

Cost Effectiveness ◽

Computerized Tomography ◽

Hodgkin's Disease ◽

Hodgkin’S Disease

MP17-11 ACTIVE SURVEILLANCE FOLLOW-UP STRATEGIES: A COST-EFFECTIVENESS ANALYSIS

The Journal of Urology ◽

10.1016/j.juro.2018.02.566 ◽

2018 ◽

Vol 199 (4S) ◽

Author(s):

Niranjan Sathianathen ◽

Badrinath Konety ◽

Fernando Alarid-Escudero ◽

Nathan Lawrentschuk ◽

Karen Kuntz

Keyword(s):

Cost Effectiveness ◽

Active Surveillance ◽

Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis

10.26226/morressier.56d6be7bd462b80296c9581d ◽

2016 ◽

Author(s):

Carmen Peral

Keyword(s):

Cost Effectiveness ◽

Invasive Aspergillosis ◽

Antifungal Therapy ◽

Primary Treatment ◽

Cost effectiveness analysis of intensive versus conventional follow up after curative resection for colorectal cancer

BMJ ◽

10.1136/bmj.328.7431.81 ◽

2004 ◽

Vol 328 (7431) ◽

pp. 81-0 ◽

Cited By ~ 78

Author(s):

A. G Renehan

Keyword(s):

Colorectal Cancer ◽

Cost Effectiveness ◽

Curative Resection ◽

PUK10 COST-EFFECTIVENESS ANALYSIS OF IMMUNOSUPPRESSIVE REGIMENS AFTER RENAL TRANSPLANTATION: REAL-WORLD PERFORMANCE IN 15 YEARS OF FOLLOW-UP IN BRAZILIAN PUBLIC HEALTH SYSTEM

Value in Health ◽

10.1016/j.jval.2020.04.1468 ◽

2020 ◽

Vol 23 ◽

pp. S378

Author(s):

R. Gomes ◽

W. Barbosa ◽

A. Guerra-Junior ◽

F.A. Acúrcio

Keyword(s):

Public Health ◽

Renal Transplantation ◽

Cost Effectiveness ◽

Health System ◽

Real World ◽

Public Health System ◽

Cost-Effectiveness Analysis for Surgical, Angioplasty, or Medical Therapeutics for Coronary Artery Disease: 5-Year Follow-Up of Medicine, Angioplasty, or Surgery Study (MASS) II Trial

Circulation ◽

10.1161/circulationaha.111.084442 ◽

2012 ◽

Vol 126 (11_suppl_1) ◽

pp. S145-S150 ◽

Cited By ~ 21

Author(s):

R. D. Vieira ◽

W. Hueb ◽

M. Hlatky ◽

D. Favarato ◽

P. C. Rezende ◽

...

Keyword(s):

Coronary Artery Disease ◽

Cost Effectiveness ◽

Coronary Artery ◽

Effectiveness Analysis ◽

Artery Disease ◽

Medical Therapeutics

The model-based cost-effectiveness analysis of 1-year adjuvant trastuzumab treatment: based on 2-year follow-up HERA trial data

Breast Cancer Research and Treatment ◽

10.1007/s10549-007-9679-4 ◽

2007 ◽

Vol 109 (3) ◽

pp. 559-566 ◽

Cited By ~ 38

Author(s):

Takeru Shiroiwa ◽

Takashi Fukuda ◽

Kojiro Shimozuma ◽

Yasuo Ohashi ◽

Kiichiro Tsutani

Keyword(s):

Cost Effectiveness ◽

Trial Data ◽

Adjuvant Trastuzumab ◽

Trastuzumab Treatment ◽

Model Based ◽